Because the ability of SRSF1 overexpression to activate a tumor-suppressing senescence response is dependent on an intact p53 pathway, the identified SRSF1-overexpressing tumor types revealed characteristics of p53 inactivation [78]. The gene discussed is TP53; the disease is neoplasm.